# Triple in Asthma Dose Finding

> **NCT02127866** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 211 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CHF 5259 plus Foster 100/6 µg
- **DRUG:** Foster 100/6 µg (four puffs BID)

## Key facts

- **NCT ID:** NCT02127866
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-11
- **Primary completion:** 2015-03-08
- **Final completion:** 2015-03-08
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02127866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02127866, "Triple in Asthma Dose Finding". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02127866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*